Table 3.

Summary of gaze towards ROIs across four trial types and between-region significance test.

	Group mean level gaze to ROIs		Difference
Human face	Eyes	Mouth
Trial 1: blinking (silent)	0.60 (0.34) 0.00–1.00	0.07 (0.11) 0.00–0.38	t(50) = 10.14, p < 0.001, d = 1.59
Trial 2: mouth moving (silent)	0.18 (0.18) 0.00–0.82	0.46 (0.32) 0.00–0.89	t(50) = 5.79, p < 0.001, d = 0.82
Trial 3: static	0.47 (0.30) 0.00–1.00	0.22 (0.25) 0.00–0.88	t(50) = 3.85, p < 0.001, d = 0.80
Trial 4: static	0.28 (0.27) 0.00–0.97	0.22 (0.24) 0.00–0.88	t(50) = 1.17, p = 0.248, d = 0.17
Trial 5: talking	0.19 (0.18) 0.00–0.80	0.51 (0.31) 0.00–1.00	t(50) = 5.75, p < 0.001, d = 0.99
People vs. geometry	People	Geometry
Same-size (4 trials averaged)	0.40 (0.21) 0.00–0.77	0.14 (0.12) 0.00–0.49	t(50) = 7.07, p < 0.001, d = 1.22
Embedded (2 trials averaged)	0.48 (0.29) 0.00–0.94	0.15 (0.18) 0.00–0.75	t(50) = 6.07, p < 0.001, d = 1.00
Biological motion PLD	Upright Figure	Inverted Figure
(2 trials averaged)	0.38 (0.19) 0.00–0.79	0.29 (0.19) 0.00–0.62	t(50) = 2.71, p = 0.009, d = 0.39
Referential attention	Target	Distractor
(2 trials)	0.13 (0.10) 0.00–0.38	0.04 (0.05) 0.00–0.22	t(50) = 5.99, p < 0.001, d = 0.82
	Agent face/hand
	0.23 (0.14) 0.00–0.48	(vs. target)	t(50) = 5.01, p < 0.001, d = 0.68

ROIs  regions of interest.